ID

22956

Beschreibung

Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study; ODM derived from: https://clinicaltrials.gov/show/NCT00539448

Link

https://clinicaltrials.gov/show/NCT00539448

Stichworte

  1. 18.06.17 18.06.17 -
Hochgeladen am

18. Juni 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes Mellitus, Type 1 NCT00539448

Eligibility Diabetes Mellitus, Type 1 NCT00539448

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
newly diagnosed type i diabetic patients
Beschreibung

ID.1

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011854
UMLS CUI [1,2]
C1320655
type i diabetes treated with basal-bolus regimen including 3 or more injections of regular human insulin per day
Beschreibung

ID.2

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011854
UMLS CUI [1,2]
C0087111
bmi, 26-40 kg/m2
Beschreibung

ID.3

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
hba1c, 7.5%-10%
Beschreibung

ID.4

Datentyp

boolean

Alias
UMLS CUI [1]
C0019018
median 2hrs post -prandial more than or equal to 140 mg/dl (more than or equal to 7.8 mmol/l)
Beschreibung

ID.5

Datentyp

boolean

Alias
UMLS CUI [1]
C0428554
fpg more than or equal to 120 mg/dl (more than or equal to 6.7 mmol/l)
Beschreibung

ID.6

Datentyp

boolean

Alias
UMLS CUI [1]
C0428554
willingness to accept, and ability to inject insulin glargine therapy
Beschreibung

ID.7

Datentyp

boolean

Alias
UMLS CUI [1]
C0557978
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy : the use of lantus & apidra during pregnancy is not contraindicated. however, in the absence of supportive data, sanofi- aventis pharmaceuticals cannot specifically recommend the use of lantus in this patient population
Beschreibung

ID.8

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial
Beschreibung

ID.9

Datentyp

boolean

Ähnliche Modelle

Eligibility Diabetes Mellitus, Type 1 NCT00539448

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
newly diagnosed type i diabetic patients
boolean
C0011854 (UMLS CUI [1,1])
C1320655 (UMLS CUI [1,2])
ID.2
Item
type i diabetes treated with basal-bolus regimen including 3 or more injections of regular human insulin per day
boolean
C0011854 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
ID.3
Item
bmi, 26-40 kg/m2
boolean
C1305855 (UMLS CUI [1])
ID.4
Item
hba1c, 7.5%-10%
boolean
C0019018 (UMLS CUI [1])
ID.5
Item
median 2hrs post -prandial more than or equal to 140 mg/dl (more than or equal to 7.8 mmol/l)
boolean
C0428554 (UMLS CUI [1])
ID.6
Item
fpg more than or equal to 120 mg/dl (more than or equal to 6.7 mmol/l)
boolean
C0428554 (UMLS CUI [1])
ID.7
Item
willingness to accept, and ability to inject insulin glargine therapy
boolean
C0557978 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.8
Item
pregnancy : the use of lantus & apidra during pregnancy is not contraindicated. however, in the absence of supportive data, sanofi- aventis pharmaceuticals cannot specifically recommend the use of lantus in this patient population
boolean
C0032961 (UMLS CUI [1])
ID.9
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial
boolean

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video